E1912 | NCICIRB

Submitted by dcc on Thu, 2017-02-16 13:44

Study Title:

A Randomized Phase III Study of Ibrutinib (PCI- 32765)-based Therapy vs Standard Fludarabine; Cyclophosphamide; and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)

CIRB:

Adult CIRB - Late Phase Emphasis

Lead Group:

ECOG

Status:

Closed to Accrual. Pts Still Rcving Intervention

Review Status:

Available to Open